FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity
Abstract Cancer stem-like cells (CSC) contribute to therapy resistance and recurrence. Focal adhesion kinase (FAK) has a role in CSC regulation. We determined the effect of FAK inhibition on breast CSC activity alone and in combination with adjuvant therapies. FAK inhibition reduced CSC activity and...
Guardado en:
Autores principales: | Simon Timbrell, Hosam Aglan, Angela Cramer, Phil Foden, David Weaver, Jonathan Pachter, Aoife Kilgallon, Robert B. Clarke, Gillian Farnie, Nigel J. Bundred |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0042b7fcefc749e8a9c051f9adcd6bb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.
por: Gillian Farnie, et al.
Publicado: (2013) -
FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro
por: Vincent Yeung, et al.
Publicado: (2021) -
Cancer associated fibroblast FAK regulates malignant cell metabolism
por: Fevzi Demircioglu, et al.
Publicado: (2020) -
To write alone or not to write alone, that is the question
por: Vance DE
Publicado: (2013) -
LOXL2 attenuates osteoarthritis through inactivating Integrin/FAK signaling
por: Caixia Zhang, et al.
Publicado: (2021)